Kenvue Inc. Kenvue Inc.

Kenvue Inc.

KVUE

Rangering i aksjer #662
Kenvue Inc. functions as a global leader in the consumer health sector. The... Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
Aksjekurs
$19.29
Markedsverdi
$37.05B
Endring (1 dag)
2.23%
Endring (1 år)
28.94%
Land
US
Handel Kenvue Inc. (KVUE)

Kategori

Consumer Defensive
Utbytteavkastning for Kenvue Inc. (KVUE)
Kenvue Inc. (aksjesymbol: KVUE) sin utbytteavkastning (TTM) per 2023-12-31 er: 36.56%
Gjennomsnittlig utbytteavkastning de siste 5 årene: 8.08%
Utbytteavkastning for Kenvue Inc. (KVUE) fra 2019 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
2026 (TTM) 5.79% 51.17%
2024 3.83% -89.52%
2023 36.56% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter